VanEck Associates
LH icon

VanEck Associates’s Labcorp LH Stock Holding History

VanEck Associates’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.55M Sell
9,561
-644
-6% -$174K ﹤0.01% 942
2025
Q4 		$2.56M Sell
10,205
-459
-4% -$122K ﹤0.01% 946
2025
Q3 		$3.06M Sell
10,664
-672
-6% -$180K ﹤0.01% 907
2025
Q2 		$2.98M Sell
11,336
-3,784
-25% -$921K ﹤0.01% 893
2025
Q1 		$3.52M Buy
15,120
+2,001
+15% +$486K ﹤0.01% 839
2024
Q4 		$3.01M Sell
13,119
-749
-5% -$172K ﹤0.01% 868
2024
Q3 		$3.05M Buy
13,868
+694
+5% +$153K ﹤0.01% 813
2024
Q2 		$2.68M Buy
13,174
+11,869
+910% +$2.41M ﹤0.01% 791
2024
Q1 		$285K Buy
1,305
+51
+4% +$11.2K ﹤0.01% 1129
2023
Q4 		$285K Sell
1,254
-5,550
-82% -$1.17M ﹤0.01% 1121
2023
Q3 		$1.37M Sell
6,804
-2,848
-30% -$601K ﹤0.01% 816
2023
Q2 		$2M Buy
9,652
+3,485
+57% +$676K ﹤0.01% 729
2023
Q1 		$1.22M Buy
6,167
+57
+0.9% +$11.7K ﹤0.01% 790
2022
Q4 		$1.24M Sell
6,110
-11,205
-65% -$2.19M ﹤0.01% 761
2022
Q3 		$3.05M Buy
17,315
+837
+5% +$171K 0.01% 557
2022
Q2 		$3.32M Sell
16,478
-1,526
-8% -$325K 0.01% 556
2022
Q1 		$4.08M Buy
18,004
+2,060
+13% +$484K 0.01% 549
2021
Q4 		$4.3M Buy
15,944
+11,699
+276% +$2.9M 0.01% 538
2021
Q3 		$1.03M Buy
4,245
+871
+26% +$220K ﹤0.01% 804
2021
Q2 		$800K Buy
3,374
+227
+7% +$51.7K ﹤0.01% 838
2021
Q1 		$690K Buy
+3,147
New +$632K ﹤0.01% 801

Other funds holding LH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VanEck Associates's LH Position: Q1 2026 in Review

VanEck Associates reduced its Labcorp (LH) stake by 6.3% in Q1 2026, selling an estimated $174K and leaving 9,561 shares worth $2.55M. The position accounts for ﹤0.01% of the portfolio, ranked #942.

VanEck Associates first reported a position in LH in Q1 2021 and has held it in 21 quarters since. The position peaked at $4.3M in Q4 2021. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • VanEck Associates held 9,561 shares of Labcorp worth $2.55M as of Q1 2026.
  • VanEck Associates sold 644 Labcorp shares in Q1 2026, an estimated $174K.
  • Labcorp made up ﹤0.01% of VanEck Associates's portfolio in Q1 2026, its #942 holding.
  • VanEck Associates first reported a position in Labcorp in Q1 2021 and has held it in 21 quarters since.
  • VanEck Associates's Labcorp position peaked at $4.3M in Q4 2021.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on VanEck Associates's 13F filing for Q1 2026, filed 15 May 2026.